Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
Clinical trial NCT03586999 · COMPLETED
Trial details
- NCT number
- NCT03586999
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2021-05-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.